SpyGlass Pharma SGP
NASDAQ SGP
$33.56 -0.63 (-1.83%)
As of: Nov 11, 2026 · 10:52 AM EST

SpyGlass Pharma (SGP) Change in Other Operating Assets (2025 - 2026)

Updated

Analysis

SpyGlass Pharma (SGP) Change in Other Operating Assets (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Assets Change (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -122.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -251.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 32.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 SpyGlass Pharma 1.14 Bn 534.30 Mn - -114,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -114,000.00
Mar 31, 2026 1.33 Mn
Jun 30, 2025 -100,000.00
Mar 31, 2025 74,000.00
API Access

SpyGlass Pharma Change in Other Operating Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-assets&ticker=SGP&period=max&api_key=YOUR_API_KEY